Washington Multistate Pharmacy Jurisprudence MPJE Practice Exam

Question: 1 / 445

What must entities engaged in large volume compounding, particularly of sterile products, do?

Voluntarily withdraw from the market

Submit an annual report to the FDA

Voluntarily register with FDA

Entities engaged in large volume compounding, particularly of sterile products, are required to voluntarily register with the FDA. This means that they must notify the FDA of their compounding activities and comply with any necessary regulations. Option A, voluntarily withdrawing from the market, is incorrect because it would not address the issue of large volume compounding. Option B, submitting an annual report to the FDA, is incorrect because it is not a requirement for compounding entities to submit reports. Option D, purchasing liability insurance, is incorrect because it is not specified as a requirement for entities engaged in large volume compounding.

Get further explanation with Examzify DeepDiveBeta

Purchase liability insurance

Next Question

Report this question

Download Washington Multistate Pharmacy Jurisprudence MPJE Practice Exam PDF Study Guide
Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy